<DOC>
	<DOCNO>NCT01064167</DOCNO>
	<brief_summary>The aim prospective , randomize , double-blinded , placebo-controlled study evaluate effect tranexamic acid , synthetic antifibrinolytic drug , postoperative bleeding transfusion requirement patient undergo off-pump coronary artery bypass graphing ( OPCAB ) surgery .</brief_summary>
	<brief_title>Tranexamic Acid Off-pump Coronary Surgery</brief_title>
	<detailed_description>Cardiac surgical procedure account large amount allogeneic transfusion . Although postoperative bleeding seem attenuate avoidance cardiopulmonary bypass ( CPB ) , hemorrhagic complication completely eliminate consequent need allogeneic transfusion still major problem OPCAB . Tranexamic acid , synthetic antifibrinolytic drug , show reduce blood loss transfusion requirement cardiac surgery CPB . About 30 % patient OPCAB study still receive transfusion . A small sample size study concern use OPCAB surgery , find tranexamic acid appear effective reduce postoperative bleeding , however , result transfusion requirement still inconsistency . The purpose study evaluate effect tranexamic acid postoperative bleeding transfusion requirement large number patient undergo OPCAB surgery . In addition , effect tranexamic acid mortality , morbidity resource utilization examine .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients elective offpump coronary artery bypass surgery A history bleed disorder Active chronic hepatitis cirrhosis Chronic renal insufficiency ( serum creatinine &gt; 2 mg/dL ) Preoperative anemia ( Hb &lt; 10 g/dL ) Previous cardiac surgery Myocardial infarction &lt; 7 day surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>off-pump coronary Artery Bypass</keyword>
</DOC>